Skip to main content
Premium Trial:

Request an Annual Quote

Memory Pharmaceuticals and Monogram Biosciences Awarded US Patents

Premium
Memory Pharmaceuticals has been awarded US Patent 7,358,057, “QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells.”
 
The inventors listed on the patent are Daguang Wang and Michael De Vivo.
 
The patent describes QM-7 or QT-6 cells comprising a heterologous mutant nicotinic α7 acetylcholine receptor and/or a nucleic acid encoding it, the abstract said. These QM-7 and QT-6 cells are useful for assays such as high-throughput assays that measure the influx of cations into a cell.
 

 
Monogram Biosciences has been awarded US Patent 7,358,052, “Catalytic amplification of multiplexed assay signals.”
 
The inventor listed on the patent is Sharat Singh.
 
Its abstract said that the patent describes methods, compositions, kits, and a system for detecting one or more analytes in a sample. A mixture comprising the sample; a first binding reagent comprising a cleavage-inducing moiety and a first binding agent specific for an analyte; and one or more electrophoretic probes, each having a second binding agent, is subjected to conditions under which binding of respective binding agents occurs. The interaction between the binding agents and the analyte brings the cleavage-inducing moiety close enough to cleave the linkage tethering an electrophoretic tag to the second binding agent, thereby releasing the tag for electrophoretic separation. Separation of different tags occurs because of their distinct electrophoretic mobilities. After separation, a signal amplification moiety on each tag is activated to generate a signal to indicate the presence of a particular analyte.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.